News

Latest News
Jan 8, 2020

Mylan N.V. (NASDAQ: MYL) today announced that its U.S. based Mylan Pharmaceuticals business is conducting a voluntary nationwide recall, to the consumer level, of three lots of Nizatidine...

Jan 6, 2020

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that Chairman Robert J. Coury, together with Upjohn's Group President Michael Goettler and Mylan's President Rajiv Malik,...

Dec 18, 2019

Pfizer Inc. (NYSE: PFE) and Mylan N.V. (NASDAQ: MYL) today announced that Ian Read and James Kilts will join the Viatris board of directors upon completion of the planned combination of Mylan N.V....

Dec 2, 2019

Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced the U.S. launch of Ogivri™ (trastuzumab-dkst), a biosimilar to Herceptin® (trastuzumab). Ogivri is...

Nov 25, 2019

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it will present at the Evercore ISI HealthCONx Conference in Boston on Tuesday, Dec. 3, 2019 at 11 a.m. ET. Interested...

View More

Search News Releases
Contact Mylan Communications

Global Communications 
724.514.1968
communications@mylan.com

Stay Connected

Mylan: Seeing is Believing

You are leaving Mylan.com

By clicking Continue below you are leaving Mylan.com and going to a third-party site.